Literature DB >> 19001176

Leflunomide-associated progressive multifocal leukoencephalopathy.

Megan Rahmlow1, Elizabeth A Shuster, Jacob Dominik, H Gordon Deen, Dennis W Dickson, Allen J Aksamit, Hector A Robles, William D Freeman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19001176     DOI： 10.1001/archneur.65.11.1538

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  21 in total

Review 1.  Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis.

Authors:  Jens Ingwersen; Orhan Aktas; Hans-Peter Hartung
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

2.  Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.

Authors:  Nuria Sola-Valls; María Sepúlveda; Yolanda Blanco; Albert Saiz
Journal:  Curr Treat Options Neurol       Date:  2015-01       Impact factor: 3.598

3.  [Nervous system side effects of disease modifying treatments of rheumatoid arthritis].

Authors:  A Rubbert-Roth; H-F Petereit
Journal:  Z Rheumatol       Date:  2012-09       Impact factor: 1.372

Review 4.  Safety, tolerability, and efficacy of oral therapies for relapsing-remitting multiple sclerosis.

Authors:  Jiwon Oh; Paul W O'Connor
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

Review 5.  Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.

Authors:  Jiwon Oh; Paul W O'Connor
Journal:  Ther Adv Neurol Disord       Date:  2014-09       Impact factor: 6.570

Review 6.  Managing Risks with Immune Therapies in Multiple Sclerosis.

Authors:  Moritz Förster; Patrick Küry; Orhan Aktas; Clemens Warnke; Joachim Havla; Reinhard Hohlfeld; Jan Mares; Hans-Peter Hartung; David Kremer
Journal:  Drug Saf       Date:  2019-05       Impact factor: 5.606

Review 7.  Infection risk in patients on multiple sclerosis therapeutics.

Authors:  Eric M Williamson; Joseph R Berger
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

8.  Inflammatory infratentorial progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis.

Authors:  Boleslaw Lach; Barbara Connolly; Christian Wüthrich; Igor J Koralnik
Journal:  Neuropathology       Date:  2013-05-20       Impact factor: 1.906

Review 9.  Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.

Authors:  Deanna Saylor; Arun Venkatesan
Journal:  Curr Infect Dis Rep       Date:  2016-11       Impact factor: 3.725

Review 10.  The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.

Authors:  Benedikt Kretzschmar; Hannah Pellkofer; Martin S Weber
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.